XBI — SPDR S&P Biotech ETF
—
PCX ·
Health Care ·
Developed Markets ·
CIK ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Max Pain — expiry 2026-12-18
max pain strike: $94.00 · spot: $145.04 · call oi: 2,908 · put oi: 12,008
Expected Move to 2026-12-18:
±$11.99
(8.27%) —
implied range
$133.05 –
$157.03
· ATM straddle on $145.00 strike
News headlines (Yahoo Finance, 1h cache)
Three FDA Decisions Loom After Summit’s Rejection — Capricor, Savara, Alzheimer’s Data Top Biotech’s Watchlist
2026-11-16 02:25 · Yahoo
Bank of America Sees Up to 95% Upside in 2 Stocks
2026-11-12 23:06 · Yahoo
Biotech Beats SPY And QQQ In Market Rout — Now Hims Earnings And Summit’s FDA Test Take Center Stage
2026-11-09 01:16 · Yahoo
IYH and XBI: Two Distinct Paths to Investing in Healthcare
2026-11-07 17:35 · Yahoo
Decoding Healthcare ETFs: Different Sectors, Different Strategies
2026-11-07 15:35 · Yahoo
Healthcare ETFs in 2026: Biotech Leads, Medical Devices Lag
2026-11-03 19:18 · Yahoo
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)?
2026-10-26 09:20 · Yahoo
Stocktwits Pharma Pulse: Big Pharma Earnings, Cancer Updates And 2 FDA Deadlines — The Week’s Biotech Watchlist
2026-10-26 02:28 · Yahoo
Madrigal’s MASH Drug Shows Improvements In Liver Health Across 4 Studies, Days After Company Disclosed $1.1B Rezdiffra Sales
2026-11-05 17:25 · Yahoo
Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge
2026-11-02 19:54 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.